The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts.
Fox26 Houston's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
FDA advisers: Popular nasal decongestant ineffective for congestion relief
Headline from Fox26 Houston ·
Newest
Popular OTC medicines for colds and allergies don’t work, FDA panel says
The FDA assembled advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind counters.
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts.
The FDA ruled that phenylephrine, a key ingredient in many over-the-counter cold medications, does not actually work to treat nasal congestion when taken orally. The agency will now need to determine if it will revoke the ingredient's oral OTC designation as “safe and effective.”
If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves.
WASHINGTON (AP) — The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.
In a unanimous vote, advisors said oral versions of phenylephrine – a nasal decongestant found in versions of drugs like Nyquil and Benadryl – isn’t effective.
By Jen Christensen, CNN (CNN) — The US Food and Drug Administration is re-evaluating the effectiveness of phenylephrine, a medication in many over-the-counter drug products that treat nasal and sinus congestion.
The Food and Drug Administration reviewed data on phenylephrine, an ingredient in many popular decongestants, and deemed it ineffective when taken orally.
For decades, sick people have been taking essentially worthless over-the-counter cold remedies to clear their stuffy noses, a key advisory panel for the U.S. Food and Drug Administration said Tuesday.
The FDA assembled its outside advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient – pseudoephedrine – were moved behind pharmacy counters.
Advisers to the Food and Drug Administration voted unanimously against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications sold on pharmacy shelves.
The main ingredient in popular oral decongestants doesn’t seem to work, advisers to the Food and Drug Administration said Tuesday in a unanimous vote that could result in the products being withdrawn from store shelves.
The U.S. Food and Drug Administration is re-evaluating the effectiveness of phenylephrine, a medication in many over-the-counter drug products that treat nasal and sinus congestion.
WASHINGTON >> The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.
A panel of advisers to the FDA concluded that a common ingredient in cold and allergy medication doesn't actually work. That could lead the agency to pull these products from store shelves.
Showing the first 25 of 32 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA advisers: Popular nasal decongestant ineffective for congestion relief | Since Then
